Netscientific Share Discussion Threads

[blakieboy7] 11/6/2022 06:00

Yes Peaky! Arrived yesterday- my thoughts exactly! What a waste of paper and postage

[peaky01] 10/6/2022 23:08

Did any of you boys get the big annual report via post! Looks fab but what a waste of money and paper!

[kingston78] 08/6/2022 08:35

We all need medicine during our life time. Pharmaceutical companies will always exist and make money. However, their traditional R&D costs heavily and takes a long time to discover new drugs. Biotech companies target a particular disease using advanced science filtering out the good and bad drug candidates more quickly and cheaply.

[btgman] 07/6/2022 23:19

Impressive interview biotec market has taken a ridiculous hit of late I know things always go to far in the wrong direction but pdsb and nsci have been wrongly hit. Pdsb current broker notes are over 4 times current share price. The interview points to this fact market is wrongly ignoring the significance of multiple phase 2 trials

AIMHO
GLA
BTg

[blakieboy7] 07/6/2022 15:29

Ilian interview with Katie hTtps://www.proactiveinvestors.co.uk/companies/news/984249/netscientific-plc-discusses-fda-fast-track-of-its-portfolio-company-s-cancer-treatment-984249.html

[blakieboy7] 02/6/2022 19:53

PDSB up 13.5% so far

[kingston78] 30/5/2022 09:10

Please note that the MACD line is about to cross the signal line upwards. Invariably when this happens the share price will rise as soon as it crosses over. It is unstoppable.

[blakieboy7] 30/5/2022 08:05

Lots to look forward to with PDSB

[senttothegallows] 30/5/2022 07:35

PDSB up circa 8% in US Friday should break £1 today IMHO

[peaky01] 27/5/2022 15:53

Decent RNS

[kingston78] 27/5/2022 14:46

On an intraday basis as I write, the share chart is showing promise with momentum ticking upwards and the MACD signal line (to buy or to sell) about to cross upwards ( a buy signal).

Recent intraday high was about 95 -96 p. This needs to be cleared first, but I don't see any overhead resistance to stop this share from moving to 120 p-130 p.

[tomboyb] 27/5/2022 14:41

Good RNS -

[kingston78] 27/5/2022 08:48

The share price is taking a pause, as it appears that some investors are selling (hopefully for a profit if they got in at a lower level). The MACD convergence/divergence signal line seems to me about to cross upwards, which if it does, will be another leg up for the share price.

[kingston78] 27/5/2022 08:40

PDSB will host a conference call.

Conference Call on Tuesday, June 7, 2022 at 8:00 AM EDT
FLORHAM PARK, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines, today announced its management team will host a conference call following two poster presentations of PDS0101 data at 2022 American Society of Clinical Oncology Meeting (ASCO).
During the call, PDS Biotech will review data from the two poster presentations:

National Cancer Institute (NCI)-led Phase 2 clinical trial, which studies PDS0101 in combination with two investigational immune-modulating agents for the treatment of advanced refractory HPV-associated cancers and;
VERSATILE-002 Phase 2 trial of PDS0101 in combination with Merck’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) for treatment of recurrent or metastatic HPV16-positive head and neck cancer.
Following the presentation, PDS Biotech will hold a question-and-answer session.

[loafofbread] 27/5/2022 08:21

I can't believe they won't RNS the excellent trial updates from PDSB sometime today.

PDSB is worth a lot more than $150M after those results!

[kingston78] 25/5/2022 14:19

A company called Angle has just received an FDA clearance for its medical device for the capture and harvest of circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent analysis. Upon this announcement Angle's share has jumped 62% today. It is now capitalised at £375 million.

If any one of NSCI's investment bears fruit, even at a fraction of the success of Angle, mentioned above, the value of NSCI will multiply.

[loafofbread] 24/5/2022 17:25

Some decent buying this afternoon.

[blakieboy7] 23/5/2022 13:59

htTps://www.voxmarkets.co.uk/articles/traders-cafe-with-zak-mir-ilian-iliev-ceo-john-clarkson-chairman-netscientific-3cacdf3/

[loafofbread] 23/5/2022 13:56

Can you post the link for people who missed it.

[senttothegallows] 23/5/2022 13:08

The Traders Cafe interview is worth a listen. NSCI clearly have a strong asset portfolio that is going places. Still way to cheap down here £1.50+ is more realistic IMHO

[kingston78] 23/5/2022 11:34

I have previously mentioned the candle charting term "three marching soldiers". I have reviewed the chart again, and there were several setbacks in between the three large white (rising, upward movement) candles.

When a "three marching soldiers" formation is seen it is invariably an indication of buyers overwhelming sellers significantly such that the upward price movement is unstoppable (by way of analogy, think of ocean current moving in a particular direction).

Coupled with the recent news announcements, I am extremely positive about NSCI to reach at least 120 p and then 130 p before it takes a breather.

[blakieboy7] 23/5/2022 09:56

Great start to the day

[kingston78] 23/5/2022 09:17

The share chart is poised to go up to 120 p without any resistance.